158 engineering-computation "https:" "https:" "https:" "https:" "https:" "https:" "https:" "CNRS " positions at Leibniz in Germany
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
science, composite engineering, interfacial mechanics, and chemical polymer design to eastablish a new binder type that is suitable for industrially scalable dry electrode processing. The successful
-
, computer science, medicine, pharmacology, and physics. ISAS is a member of the Leibniz Association and is publicly funded by the Federal Republic of Germany and its federal states. At our location in
-
The Leibniz-Institut für Kristallzüchtung (IKZ) is a leading research institution in the field of science & technology as well as service & transfer of crystalline materials. Our goal is to enable
-
cooperation partners in their research projects with state-of-the-art light and electron microscopes (https://www.leibniz-fmp.de/cellular-imaging ). We work with proteins, cell cultures, and model organisms
-
of nutrition and health, with the aim of understanding the molecular basis of nutrition-dependent diseases, and of developing new strategies for treatment and prevention (https://www.dife.de/en/). We invite
-
in a state-of-the art, international research environment with excellent technical facilities Structured training within the LIV Graduate School, an interdisciplinary PhD program for all doctoral
-
The Leibniz-Institut für Kristallzüchtung (IKZ) is a leading research institution in the field of science & technology as well as service & transfer of crystalline materials. Our goal is to enable
-
digitalization and medical needs. Our research integrates materials chemistry, biological processes, physical analysis, and process engineering. We aim for leadership in the fields of opto-interactive, electro
-
mentorship in the career development of the student. The program language is English. We offer: a highly international research environment and state-of-the-art technology four years of full funding through
-
candidate will join an exciting research program exploring a newly emerging paradigm in immunology: mitochondrial transfer and synthetic organelle therapy. Using newly developed genetically engineered mouse